期刊文献+

盐酸法舒地尔对急性脑梗死患者血清超敏C反应蛋白和血管内皮生长因子的影响 被引量:1

The effectiveness of fasudil on hs-CRP and VEGF of patients with acute cerebral infarction
下载PDF
导出
摘要 目的观察盐酸法舒地尔对急性脑梗死患者血清超敏C反应蛋白和血管内皮生长因子的影响。方法 86例急性脑梗死患者随机分为两组,治疗组46例,对照组40例。对照组采用常规治疗,治疗组在常规治疗基础上加用法舒地尔,共观察21 d。治疗前后测定血清超敏C反应蛋白(hs-CRP)和血管内皮生长因子(VEGF)。结果两组在治疗7、21 d后神经功能均有明显好转,并且治疗组改善程度在7、21 d均优于对照组(P<0.05)。两组在治疗后hs-CRP和VEGF均有显著降低,并且治疗组降低程度更明显(P<0.05)。结论法舒地尔可以减少急性脑梗死患者hs-CRP和VEGF的表达,从而改善病情。 Objective To study the effectiveness of fasudil on high sensitivity C-reactive protein (hs- CRP) and vascular endothelial growth factor (VEGF)of patients with acute cerebral infarction. Methods Eighty-six patients with acute cerebral infarction were randomly divided into two groups, the control group ( n = 40 cases) and the treatment group( n =46 cases). The patients in the control group were treated through conven- tional treatment and the treatment group through conventional plus fasudil treatment. They were treated for twen- ty-one days. The hs-CRP and VEGF were detected before and after treatment. Results The nerve function were improved after treatment for both groups, moreover the nerve function in the treatment group was better than that in the control group( P 〈 0. 05 ). hs-CRP and VEGF in both groups were decreased after treatment. There was a significant difference between two groups (P 〈 0. 05 ). Conclusion Fasudil could decrease hs-CRP and VEGF of patients with acute cerebral infarction.
作者 王芳 刘爱中
出处 《中国实用医药》 2012年第21期3-5,共3页 China Practical Medicine
关键词 脑梗死 法舒地尔 超敏C反应蛋白 血管内皮生长因子 Cerebral infarction fasudil hs-CRP VEGF
  • 相关文献

参考文献14

  • 1贾建平.神经病学.第6版.北京:人民卫生出版社,2010:171-183.
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 3曾凤兰.C-反应蛋白与冠心病的研究进展[J].医学综述,2003,9(7):411-412. 被引量:25
  • 4张微微,周小英,黄勇华.不同类型脑梗死患者血清C-反应蛋白的检测及临床意义[J].中华检验医学杂志,2004,27(11):781-783. 被引量:35
  • 5Patrick L,Uzick M.Cardiovascular disease; G-reactive protein and the inflammatory disease paradigm:HMG-GoA reductase inhibitors,alpha-tocopherol,red yeast rice,and olive oil polyphenols.A review of the literature.Altem Med Rev,2001,6(3):248-271.
  • 6Kimura R,Nakase H,Tamaki R,et al.Vascular endothelial growth factor antagonist reduces brain edema formation and veoous infaretion. Stroke,2005,36(6):1259.
  • 7Gora-KupilasK,Josko J.The neuroproteetive function of vasclllar endothelial growth factor (VEGF).Folia Neuropathol,2005,43 (1):31-39.
  • 8Shvin M,Krupinski J,Slowik A,et al.Serial measurement of vascular endothelial growth factor and transforming growth factor-βl in serum of patients with acute ischemic stoke.Stoke,2000,31 (8):1863-1870.
  • 9Shah DI,Singh M.Involvement of Rho-kinase in experimentalvas-cular endothelial dysfunction.Mol Cell Bioehem,2006,283 (8):191-199.
  • 10Satoh S,Toshima Y,Ikegakil,et al.Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gethils.Brain Res,2007,1128:175-180.

二级参考文献24

  • 1Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C- reactive protein and serum anyloid A protein in severe umstable angina[J] .N Eng J Med,1994,331(3) :417-424.
  • 2Thompson SG, Kienast J, Pyke SOM, et al. Uemostatic factors and the risk of myocardial infarction or solden death in patients with angina pectoris[ J]. N Eng J Med, 1995,332(4) :635-641.
  • 3Rus H, Niculescu FI. Inflammation, aspirin, and the risk of cardiovascular disease[J] .N Eng J Med,1997,337(3) :423.
  • 4Luigi M, Giovanna L, Rita L, et al. Elevated levels of C-creaetive protein at discharge in patients with unstable angina predict recurrents instsbility[J]. Clin Invest Rep, 1998,11(5) : 855-859.
  • 5Rebuzzi AG, Quarante L, Liuzzo G, et al. Incremental prognostic value of serum levels of tropinin T and C-creactive protein on admission in patients with unstable angina pectoris[ J] .Am J Cardiol, 1998,82(5) :715-719.
  • 6Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-creactive protien at discharge in patient with unstable angina pectoris recurrent instability[J]. Criculation, 1999,99(20) :2079- 2084.
  • 7Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently health men[J]. N Eng J Med, 1997,336(14) :973-979.
  • 8Marrow DA, Rifai N, Antman EM, et al. C-reactive protent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI HA subs-tudly [ J ]. J Am Coll Cardiol,1998,31 (5) : 1460-1465.
  • 9Gaspardone A, Crea F, Versaci F, et al. Preadictive value of C-creacrive protein after successful coronary- artery stenting in patient with unstable angina[J]. Am J Cardiol, 1998,82(3) :515- 518.
  • 10Koenig W, Sund M, Frohlich M, et al. C-creacyive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy midle-aged men : Resolts from the MONICA angsburg cohort study 1984-1992 [ J]. Circulation, 1999,99(2) : 237-242.

共引文献33072

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部